Sell Sun Pharma, target Rs 390: Dr CK Narayan
Sell Sun Pharmaceutical Industries Ltd. at a price target of Rs 390.0 and a stoploss at Rs 420 from entry point.

Sun Pharmaceutical Industries Ltd. key Products/Revenue Segments include Pharmaceuticals which contributed Rs 7696.33 Crore to Sales Value (96.83 % of Total Sales) and Other Operating Revenue which contributed Rs 251.27 Crore to Sales Value (3.16 % of Total Sales)for the year ending 31-Mar-2018.
For the quarter ended 31-12-2018, the company has reported a Consolidated sales of Rs 7656.71 Crore, up 11.83 % from last quarter Sales of Rs 6846.48 Crore and up 16.04 % from last year same quarter Sales of Rs 6598.21 Crore Company has reported net profit after tax of Rs 1459.19 Crore in latest quarter. The company’s top management includes Mr.Ashwin Dani, Mr.Dilip S Shanghvi, Mr.Gautam Doshi, Mr.Israel Makov, Mr.Kalyanasundaram Subramanian, Mr.Keki M Mistry, Mr.S Mohanchand Dadha, Mr.Sailesh T Desai, Mr.Sudhir V Valia, Mr.Vivek Chaand Sehgal, Ms.Rekha Sethi. Company has S R B C & Co. LLP as its auditoRs As on 31-03-2019, the company has a total of 2,399,334,970 shares outstanding.
Download ET Markets APP